Tissue engineering, stem cells, and cloning for the regeneration of urologic organs

被引:21
作者
Atala, A
机构
[1] Childrens Hosp, Dept Urol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1016/S0094-1298(03)00094-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Selective cell growth and biomaterials have led to the engineering of urologic tissues and organs that may be used to restore and maintain normal function. Cells for tissue reconstitution can be derived from the native organ to be replaced, thus avoiding rejection. In situations where normal native tissues are not available, different stem cell sources may be explored. In addition, recent advances in the field of cloning have made it possible to retrieve cells using nuclear transfer techniques. Fetal applications have also been explored. Tissue engineering has been applied experimentally and clinically for the reconstitution of several urologic tissues and organs. Recent progress suggests that other engineered tissues and organs created experimentally will also have clinical applicability.
引用
收藏
页码:649 / +
页数:20
相关论文
共 124 条
[41]   BIODEGRADABLE POLYMER SCAFFOLDS FOR TISSUE ENGINEERING [J].
FREED, LE ;
VUNJAKNOVAKOVIC, G ;
BIRON, RJ ;
EAGLES, DB ;
LESNOY, DC ;
BARLOW, SK ;
LANGER, R .
BIO-TECHNOLOGY, 1994, 12 (07) :689-693
[42]   Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder [J].
Freeman, MR ;
Yoo, JJ ;
Raab, G ;
Soker, S ;
Adam, RM ;
Schneck, FX ;
Renshaw, AA ;
Klagsbrun, M ;
Atala, A .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) :1028-1036
[43]  
GILDING DK, 1981, BIOCOMPATIBILITY CLI, P209
[44]   THE USE OF ALLOPLASTIC BIOMATERIALS IN BLADDER SUBSTITUTION [J].
GLEESON, MJ ;
GRIFFITH, DP .
JOURNAL OF UROLOGY, 1992, 148 (05) :1377-1382
[45]  
GORHAM SD, 1989, EUR UROL, V16, P440
[46]   IMMUNOGENICITY OF MHC CLASS-I ALLOANTIGENS EXPRESSED ON PARENCHYMAL-CELLS IN THE HUMAN KIDNEY [J].
HADLEY, GA ;
LINDERS, B ;
MOHANAKUMAR, T .
TRANSPLANTATION, 1992, 54 (03) :537-542
[47]  
Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.3.CO
[48]  
2-P
[49]  
Harris M, 2001, INT REV AFR AM ART, V18, P26
[50]  
Hiendleder S, 1999, MOL REPROD DEV, V54, P24, DOI 10.1002/(SICI)1098-2795(199909)54:1&lt